Literature DB >> 12792858

Combination therapy for aspergillosis: is it needed, and which combination?

L Joseph Wheat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12792858     DOI： 10.1086/375418

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  2 in total

Review 1.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

2.  Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients.

Authors:  Andreas H Groll; Gerda Silling; Charlotte Young; Rainer Schwerdtfeger; Helmut Ostermann; Werner J Heinz; Joachim Gerss; Hedwig Kolve; Claudia Lanvers-Kaminsky; João Paulo Vieira Pinheiro; Sibylle Gammelin; Oliver A Cornely; Gudrun Wuerthwein
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.